Impact of DME on Pulpal and Periodontal Health at Varying Gingival Seat Level

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPostgraduate Institute of Dental Sciences Rohtak

About this trial

The classical idea was to keep the biologic width untouched in order to maintain periodontal health but the newer case reports have given a new dimension to this concept, stating that a limited extension into STA can be used as an alternative for invasive procedures like SCL. The periodontal tissues can still tolerate subgingival margin placement in biologic width when restorations are free of overhangs which are real culprit for providing room for plaque retention and further inflammation. There are no sufficient clinical studies with good sample size to prove the significance of this concept. Hence, we are performing a Non Randomized Controlled trial by placing gingival margins at various levels above the alveolar crest and restoring it with composite and further evaluate the periodontal tissue health, pulpal health, restoration quality and significance of DME.

Eligibility criteria

Qualifiers

Patients at least 18 years of age at the time of treatment.

Permanent Posterior teeth exhibiting proximal caries lesion extending subgingivally below the cemento-enamel junction (CEJ). The axial extent of the caries should not be more than 75% of the dentin thickness.

Sound tooth structure of atleast 1mm should be present from the alveolar crest to the base of the cavity/ gingival seat after cavity preparation.

The tooth should either be asymptomatic or have reversible pulpitis as determined by history and pulp sensibility testing. There should be no history of spontaneous or lingering pain

Disqualifiers

Presence of bone disease (metabolic, endocrine, infectious, tumoral, developmental pathologies)

Pregnant or lactating and history of smoking or alcohol abuse

Anti inflammatory drug consumption within past 3 days

Uncontrolled or poorly controlled diabetes

Trial design

Treatments tested in this trial

  • Deep Margin Elevation

Treatment groups

81 Participants
are divided into 3 treatment groups